347
Participants
Start Date
September 30, 2004
Primary Completion Date
May 31, 2005
Study Completion Date
May 31, 2005
Bupropion Hydrochloride Extended-release
Extended-release Venlafaxine
GSK Investigational Site, New York
GSK Investigational Site, Brooklyn
GSK Investigational Site, Rockville
GSK Investigational Site, Charlottesville
GSK Investigational Site, Charlotte
GSK Investigational Site, Columbia
GSK Investigational Site, Charleston
GSK Investigational Site, Marietta
GSK Investigational Site, Smyrna
GSK Investigational Site, Jacksonville
GSK Investigational Site, Orlando
GSK Investigational Site, Coral Springs
GSK Investigational Site, Toledo
GSK Investigational Site, Cleveland
GSK Investigational Site, Indianapolis
GSK Investigational Site, Minneapolis
GSK Investigational Site, Oak Brook
GSK Investigational Site, New Orleans
GSK Investigational Site, Little Rock
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Fort Worth
GSK Investigational Site, Bellaire
GSK Investigational Site, San Antonio
GSK Investigational Site, Austin
GSK Investigational Site, Denver
GSK Investigational Site, Phoenix
GSK Investigational Site, Mesa
GSK Investigational Site, Scottsdale
GSK Investigational Site, Las Vegas
GSK Investigational Site, Beverly Hills
GSK Investigational Site, Burbank
GSK Investigational Site, Upland
GSK Investigational Site, La Mesa
GSK Investigational Site, Temecula
GSK Investigational Site, San Francisco
GSK Investigational Site, Walnut Creek
GSK Investigational Site, Portland
GSK Investigational Site, Portland
GSK Investigational Site, Eugene
GSK Investigational Site, Yakima
GSK Investigational Site, Braintree
GSK Investigational Site, Greenfield
GSK Investigational Site, Lincoln
GSK Investigational Site, Middleton
Lead Sponsor
GlaxoSmithKline
INDUSTRY